Prognostic value of a combination of innovative factors (gut microbiota, sarcopenia, obesity, metabolic syndrome) to predict surgical/oncologic outcomes following surgery for sporadic colorectal cancer: a prospective cohort study protocol (METABIOTE)

INTRODUCTION: Colorectal cancer (CRC) is still associated with poor prognosis, especially in patients with advanced disease. Development of new prognostic tools replacing or supplementing those routinely used is definitely needed, with the aim to optimise and personalise treatment strategies. Gut mi...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMJ Open
Auteurs principaux: Veziant, Julie, Poirot, Karine, Chevarin, Caroline, Cassagnes, Lucie, Sauvanet, Pierre, Chassaing, Benoit, Robin, Frederic, Godfraind, Catherine, Barnich, Nicolas, Pezet, Denis, Pereira, Bruno, Gagniere, Johan, Bonnet, Mathilde
Format: Artigo
Langue:Inglês
Publié: BMJ Publishing Group 2020
Sujets:
Oncology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6955509/
https://ncbi.nlm.nih.gov/pubmed/31915159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-031472
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires